Hesai posts strong growth and HKEX listing lowers risk, but high valuation prompts caution. Click here to read an analysis of ...
The deceleration in CKD prevalence growth after 2012, along with the declining incidence trends may reflect the impact of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback